Archives

by in
Entry Author Date Location
The Young and Proven Biotech VCs From 2012. Where Are They Now? 02/10/14 National
Juno Therapeutics Receives $120,000,000 Series A Financing Round 12/05/13 Seattle
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
NextCODE Lands $15,000,000 Series A Funding Round 10/24/13 Boston
DeCode Spinout, NextCode Health, Launches With $15M From Arch, Polaris 10/23/13 Boston
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
SAGE Therapeutics Receives $20,000,000 Series B Financing Round 10/16/13 Boston
Boreal Genomics Lands $18,000,000 Series C Round 10/07/13 San Francisco
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
Boston Roundup: Acquia, 908 Devices, StarStreet 08/30/13 Boston
Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M 08/14/13 San Diego
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Agios Rockets to $29 Per Share in Market Debut 07/24/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Ensemble Adds to Cast of Partners With Alexion Deal 07/18/13 Boston
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Syros Garners $30,000,000 Series A Financing 04/12/13 Boston
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
How to Make the Payers Pay: Join the Xconomy Event April 9 03/26/13 Seattle
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Page 2 of 13 « previous page · next page »